Display options
Cite
Avsar KB, Weller RE, Cox JE, et al. An fMRI investigation of delay discounting in patients with schizophrenia. Brain Behav. 2013;3(4):384-401doi: 10.1002/brb3.135.
Avsar, K. B., Weller, R. E., Cox, J. E., Reid, M. A., White, D. M., & Lahti, A. C. (2013). An fMRI investigation of delay discounting in patients with schizophrenia. Brain and behavior, 3(4), 384-401. https://doi.org/10.1002/brb3.135
Avsar, Kathy Burton, et al. "An fMRI investigation of delay discounting in patients with schizophrenia." Brain and behavior vol. 3,4 (2013): 384-401. doi: https://doi.org/10.1002/brb3.135
Avsar KB, Weller RE, Cox JE, Reid MA, White DM, Lahti AC. An fMRI investigation of delay discounting in patients with schizophrenia. Brain Behav. 2013 Jul;3(4):384-401. doi: 10.1002/brb3.135. Epub 2013 Apr 24. PMID: 24381810; PMCID: PMC3869680.
Copy Download .nbib Format: NLM
Share it on

Brain Behav. 2013 Jul;3(4):384-401. doi: 10.1002/brb3.135. Epub 2013 Apr 24.

An fMRI investigation of delay discounting in patients with schizophrenia.

Brain and behavior

Kathy Burton Avsar, Rosalyn Eve Weller, James Edward Cox, Meredith Amanda Reid, David Matthew White, Adrienne Carol Lahti

Affiliations

  1. Department of Psychiatry and Behavioral Neurobiology, The University of Alabama at Birmingham Birmingham, Alabama, 35294-0017 ; Department of Psychology, The University of Alabama at Birmingham Birmingham, Alabama, 35294-1170.
  2. Department of Psychology, The University of Alabama at Birmingham Birmingham, Alabama, 35294-1170.
  3. Department of Psychiatry and Behavioral Neurobiology, The University of Alabama at Birmingham Birmingham, Alabama, 35294-0017 ; Department of Biomedical Engineering, The University of Alabama at Birmingham Birmingham, Alabama, 35294-2182.
  4. Department of Psychiatry and Behavioral Neurobiology, The University of Alabama at Birmingham Birmingham, Alabama, 35294-0017.

PMID: 24381810 PMCID: PMC3869680 DOI: 10.1002/brb3.135

Abstract

Schizophrenia (SZ) is associated with a reduced ability to set meaningful goals to reach desired outcomes. The delay-discounting (DD) task, in which one chooses between sooner smaller and later larger rewards, has proven useful in revealing executive function and reward deficits in various clinical groups. We used fMRI in patients with SZ and healthy controls (HC) to compare brain activation during performance of a DD task. Prior to the neuroimaging session, we obtained each participant's rate of DD, k, on a DD task and used it to select a version of the DD task for each participant's fMRI session. Because of the importance of comparing fMRI results from groups matched on performance, we used a criterion value of R (2) > 0.60 for response consistency on the DD task to analyze fMRI activation to DD task versus control trials from consistent SZ (n = 14) and consistent HC (n = 14). We also compared activation between the groups on contrasts related to trial difficulty. Finally, we contrasted the inconsistent SZ (n = 9) with the consistent HC and consistent SZ; these results should be interpreted with caution because of inconsistent SZ's aberrant performance on the task. Compared with consistent HC, consistent SZ showed reduced activation to DD task versus control trials in executive function and reward areas. In contrast, consistent SZ showed more activation in the precuneus and posterior cingulate, regions of the default mode network (DMN) that are typically deactivated during tasks, and in the insula, a region linked to emotional processing. Furthermore, consistent SZ had abnormal activation of lateral and medial frontal regions in relation to trial difficulty. These results point to disruption of several neural networks during decision making, including the executive, reward, default mode, and emotional networks, and suggest processes that are impaired during decision making in schizophrenia.

Keywords: Delay discounting; executive function; intertemporal; reward; schizophrenia; subjective value

References

  1. Mol Psychiatry. 2008 Mar;13(3):239, 267-76 - PubMed
  2. Am J Addict. 2005 Mar-Apr;14(2):106-23 - PubMed
  3. Brain Res. 2008 Oct 9;1234:104-15 - PubMed
  4. Psychopharmacology (Berl). 1999 Oct;146(4):455-64 - PubMed
  5. Alcohol. 2006 May;39(1):1-11 - PubMed
  6. J Abnorm Psychol. 2011 May;120(2):483-9 - PubMed
  7. Am J Psychiatry. 2003 Apr;160(4):709-19 - PubMed
  8. Science. 2004 Oct 15;306(5695):503-7 - PubMed
  9. Biol Psychiatry. 2011 Mar 1;69(5):424-31 - PubMed
  10. Psychopharmacology (Berl). 2011 Jul;216(1):91-9 - PubMed
  11. Schizophr Res. 2010 Nov;123(2-3):93-104 - PubMed
  12. Psychol Bull. 1975 Jul;82(4):463-96 - PubMed
  13. Drug Alcohol Depend. 1999 Aug 2;56(1):25-32 - PubMed
  14. Behav Pharmacol. 2006 Dec;17(8):669-79 - PubMed
  15. Brain. 1999 Apr;122 ( Pt 4):593-624 - PubMed
  16. Neuroimage. 2002 Apr;15(4):870-8 - PubMed
  17. Schizophr Bull. 2010 Sep;36(5):919-34 - PubMed
  18. Brain Res Rev. 2008 Nov;59(1):96-124 - PubMed
  19. J Exp Psychol Gen. 1999 Mar;128(1):78-87 - PubMed
  20. Front Neurosci. 2011 Nov 16;5:126 - PubMed
  21. Exp Clin Psychopharmacol. 1998 Aug;6(3):292-305 - PubMed
  22. Am J Psychiatry. 1996 Mar;153(3):321-30 - PubMed
  23. J Exp Anal Behav. 1987 May;47(3):287-97 - PubMed
  24. Brain Res. 2010 Mar 12;1320:123-9 - PubMed
  25. Psychol Aging. 1996 Mar;11(1):79-84 - PubMed
  26. Cogn Neuropsychiatry. 2008 May;13(3):250-66 - PubMed
  27. Psychol Sci. 2008 Sep;19(9):904-11 - PubMed
  28. J Subst Abuse Treat. 2011 Dec;41(4):354-62 - PubMed
  29. Sci Am. 1994 Oct;271(4):144 - PubMed
  30. Schizophr Res. 2010 Aug;121(1-3):75-89 - PubMed
  31. Cereb Cortex. 2007 Sep;17 Suppl 1:i171-81 - PubMed
  32. Hum Brain Mapp. 2007 May;28(5):383-93 - PubMed
  33. Novartis Found Symp. 1998;218:64-75; discussion 75-80, 104-8 - PubMed
  34. Nat Rev Neurosci. 2001 Oct;2(10):685-94 - PubMed
  35. Brain. 2006 Mar;129(Pt 3):564-83 - PubMed
  36. Arch Gen Psychiatry. 1994 Nov;51(11):849-59; discussion 863-4 - PubMed
  37. Cereb Cortex. 2012 Jan;22(1):99-111 - PubMed
  38. Nat Neurosci. 2007 Dec;10(12):1625-33 - PubMed
  39. Psychopharmacology (Berl). 2006 Oct;188(2):162-70 - PubMed
  40. J Neurosci. 2009 Jul 29;29(30):9575-81 - PubMed
  41. Curr Pharm Des. 2010;16(18):2012-25 - PubMed
  42. Biol Psychiatry. 2011 Jan 1;69(1):55-62 - PubMed
  43. Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):676-82 - PubMed
  44. J Clin Psychopharmacol. 2007 Feb;27(1):80-4 - PubMed
  45. Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9673-8 - PubMed
  46. Am J Psychiatry. 2005 Oct;162(10):1833-9 - PubMed
  47. J Clin Exp Neuropsychol. 1998 Jun;20(3):310-9 - PubMed
  48. Schizophr Res. 2003 Apr 1;60(2-3):285-98 - PubMed
  49. Psychopharmacology (Berl). 2008 Mar;196(4):673-84 - PubMed
  50. Arch Gen Psychiatry. 2010 Dec;67(12):1246-54 - PubMed
  51. J Abnorm Psychol. 2007 May;116(2):268-78 - PubMed
  52. Schizophr Res. 2006 May;84(1):100-11 - PubMed
  53. Neuropsychopharmacology. 2008 Feb;33(3):473-9 - PubMed
  54. J Abnorm Psychol. 1999 Feb;108(1):120-33 - PubMed
  55. Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1279-84 - PubMed
  56. J Neurosci. 2009 Jul 8;29(27):8839-46 - PubMed
  57. J Abnorm Psychol. 2011 Nov;120(4):911-21 - PubMed
  58. Psychopharmacology (Berl). 2011 Jul;216(1):17-27 - PubMed
  59. Neuroimage. 2007 Oct 15;38(1):95-113 - PubMed
  60. Neuroimage. 2009 Jan 1;44(1):62-70 - PubMed
  61. Addict Behav. 2012 Jan;37(1):67-72 - PubMed
  62. Biol Psychiatry. 2008 Jul 1;64(1):62-9 - PubMed
  63. Cogn Neuropsychiatry. 2007 May;12(3):213-21 - PubMed
  64. Exp Clin Psychopharmacol. 2008 Jun;16(3):264-74 - PubMed
  65. Psychopharmacology (Berl). 1999 Oct;146(4):447-54 - PubMed
  66. J Exp Anal Behav. 2002 Mar;77(2):129-46 - PubMed
  67. Neuroimage. 2006 Jan 15;29(2):409-16 - PubMed
  68. Psychiatry Res. 2004 Jul 15;127(3):207-16 - PubMed
  69. Psychiatry Res. 2010 Feb 28;181(2):114-20 - PubMed
  70. Brain Struct Funct. 2010 Jun;214(5-6):655-67 - PubMed
  71. Neuroimage. 2005 Apr 15;25(3):653-60 - PubMed
  72. J Abnorm Psychol. 2001 Aug;110(3):482-7 - PubMed
  73. Schizophr Res. 2005 Jul 15;76(2-3):135-57 - PubMed
  74. J Abnorm Psychol. 2003 Aug;112(3):382-92 - PubMed
  75. Psychopharmacology (Berl). 2006 Aug;187(2):222-8 - PubMed
  76. Hum Brain Mapp. 2005 May;25(1):60-9 - PubMed
  77. J Psychiatry Neurosci. 2012 Jan;37(1):17-27 - PubMed
  78. Arch Gen Psychiatry. 2009 Aug;66(8):811-22 - PubMed
  79. Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):253-8 - PubMed
  80. Neuro Endocrinol Lett. 2008 Jun;29(3):351-8 - PubMed
  81. Biol Psychiatry. 2010 Oct 1;68(7):625-33 - PubMed
  82. Am J Psychiatry. 2001 Jul;158(7):1105-13 - PubMed
  83. Am J Psychiatry. 1986 Aug;143(8):993-7 - PubMed
  84. J Exp Anal Behav. 1991 Mar;55(2):233-44 - PubMed
  85. Exp Clin Psychopharmacol. 2000 May;8(2):155-62 - PubMed
  86. Psychiatry Res. 2011 Sep 30;193(3):138-43 - PubMed
  87. Appetite. 2012 Apr;58(2):582-92 - PubMed
  88. Neuroimage. 1997 May;5(4 Pt 1):261-70 - PubMed
  89. Neuropsychopharmacology. 2009 May;34(6):1567-77 - PubMed
  90. Neuroimage. 2010 Mar;50(1):223-32 - PubMed
  91. Neuroimage. 2008 Nov 15;43(3):509-20 - PubMed

Publication Types

Grant support